Liabilities, Current in USD of BriaCell Therapeutics Corp. from Q2 2021 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary
BriaCell Therapeutics Corp. quarterly Liabilities, Current history and change rate from Q2 2021 to Q2 2025.
  • BriaCell Therapeutics Corp. Liabilities, Current for the quarter ending 31 Jul 2025 was $3.98M, a 46.7% decline year-over-year.
Liabilities, Current, Quarterly (USD)
Liabilities, Current, YoY Quarterly Change (%)

BriaCell Therapeutics Corp. Quarterly Liabilities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 $3.98M -$3.48M -46.7% 31 Jul 2025 10-K 16 Oct 2025
Q1 2025 $4.33M -$2.43M -35.9% 30 Apr 2025 10-Q 16 Jun 2025
Q4 2024 $5.23M +$1.31M +33.3% 31 Jan 2025 10-Q 12 Mar 2025
Q3 2024 $4.99M +$3.94M +377% 31 Oct 2024 10-Q 16 Dec 2024
Q2 2024 $7.46M +$5.66M +314% 31 Jul 2024 10-K 16 Oct 2025
Q1 2024 $6.76M +$5.37M +389% 30 Apr 2024 10-Q 14 Jun 2024
Q4 2023 $3.92M +$3.25M +485% 31 Jan 2024 10-Q 18 Mar 2024
Q3 2023 $1.05M +$72.5K +7.44% 31 Oct 2023 10-Q 14 Dec 2023
Q2 2023 $1.8M +$860K +91.4% 31 Jul 2023 10-K 29 Oct 2024
Q1 2023 $1.38M 30 Apr 2023 10-Q 14 Jun 2023
Q4 2022 $670K 31 Jan 2023 10-Q 16 Mar 2023
Q3 2022 $974K 31 Oct 2022 10-Q 14 Dec 2022
Q2 2022 $941K +$384K +69% 31 Jul 2022 10-K 25 Oct 2023
Q2 2021 $557K 31 Jul 2021 10-K 28 Oct 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.